CVE:RVV

Revive Therapeutics Stock Forecast, Price & News

C$0.08

+0.01 (+14.29 %)

(As of 07/22/2019)

Add

Compare

Today's Range

C$0.08

▼

C$0.09

50-Day Range

C$0.08

▼

C$0.08

52-Week Range

C$0.07

▼

C$0.25

Volume212,852 shs

Average Volume93,085 shs

Market CapitalizationC$5.79 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive RVV News and Ratings via Email

Sign-up to receive the latest news and ratings for Revive Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

About Revive Therapeutics

Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

ETF Inclusion Sends Psychedelic Stock Soaring
September 21, 2021 | baystreet.ca

Revive Therapeutics expands clinical stage pipeline with Ganoderma lucidum license deal
August 20, 2021 | proactiveinvestors.com

Revive Confirms No Material Undisclosed Information
August 12, 2021 | finance.yahoo.com

Revive Therapeutics Ltd.
July 18, 2021 | barrons.com

Leede Jones Gable looking forward to final data from Revive Therapeutics Ltd's Phase 3 Bucillamine coronavirus trial
July 16, 2021 | proactiveinvestors.com

Leede Jones Gable looking forward to final data from Revive Therapeutics' Phase 3 Bucillamine coronavirus trial
July 16, 2021 | proactiveinvestors.com

Revive Therapeutics collaborates with University of Health Sciences Antigua to pioneer clinical development of psychedelics
June 19, 2021 | proactiveinvestors.com

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics
June 17, 2021 | au.finance.yahoo.com

Revive To Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
June 14, 2021 | in.finance.yahoo.com

This is Why Psilocybin May be Able to Help Millions with Mental Health Issue
May 28, 2021 | baystreet.ca

See More Headlines

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: CVE:RVV
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.revivethera.com
Phone: +1-905-6055535
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.03 per share
Price / Cash Flow: 3.18
Book Value: C$0.02 per share
Price / Book: 4.21

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.14
Quick Ratio: 6.03

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 72,411,000
Market Cap: C$5.79 million
Next Earnings Date: 11/26/2021 (Estimated)
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.21 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Revive Therapeutics.

4.4 Community Rank

Outperform Votes
Revive Therapeutics has received 59 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Revive Therapeutics has received 30 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Revive Therapeutics has received 66.29% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote “Outperform” if you believe RVV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RVV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Revive Therapeutics does not currently pay a dividend.
Dividend Growth
Revive Therapeutics does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Revive Therapeutics insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$22,896.00 in company stock and sold C$0.00 in company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Revive Therapeutics is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Revive Therapeutics is -3.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Revive Therapeutics has a P/B Ratio of 4.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Revive Therapeutics (CVE:RVV) Frequently Asked Questions

What stocks does MarketBeat like better than Revive Therapeutics?: Wall Street analysts have given Revive Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Revive Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
When is Revive Therapeutics' next earnings date?: Revive Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, November 26th 2021.
View our earnings forecast for Revive Therapeutics.
Who are Revive Therapeutics' key executives?: Revive Therapeutics' management team includes the following people:
Mr. Craig Leon, Chairman & CEO (Age 51)
Mr. Fabio Chianelli, Pres & Director (Age 41)
Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48)
Who are some of Revive Therapeutics' key competitors?: Some companies that are related to Revive Therapeutics include NetScientific (NSCI), Liberty Biopharma (LTY), Bioasis Technologies (BTI), AorTech International (AOR), Hemogenyx Pharmaceuticals (HEMO), ImmuPharma (IMM), Kane Biotech (KNE), Sigyn Therapeutics (SIGY), Midatech Pharma (MTPH), Crescita Therapeutics (CTX), Hvivo (HVO), Realm Therapeutics (RLM), Biopharmx (BPMX), Quest PharmaTech (QPT) and Medicure (MPH).
View all of RVV's competitors.
What other stocks do shareholders of Revive Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Heat Biologics (HTBX), The Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), CytoDyn (CYDY), Genprex (GNPX), iBio (IBIO), Sorrento Therapeutics (SRNE), Workhorse Group (WKHS), Acasti Pharma (ACST) and Anavex Life Sciences (AVXL).
What is Revive Therapeutics' stock symbol?: Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."
How do I buy shares of Revive Therapeutics?: Shares of RVV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Revive Therapeutics' stock price today?: One share of RVV stock can currently be purchased for approximately C$0.08.
How much money does Revive Therapeutics make?: Revive Therapeutics has a market capitalization of C$5.79 million.
What is Revive Therapeutics' official website?: The official website for Revive Therapeutics is www.revivethera.com.
Where are Revive Therapeutics' headquarters?: Revive Therapeutics is headquartered at 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada.
How can I contact Revive Therapeutics?: Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Revive Therapeutics Stock Forecast, Price & News

About Revive Therapeutics

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

1.7 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio

Revive Therapeutics (CVE:RVV) Frequently Asked Questions

What stocks does MarketBeat like better than Revive Therapeutics?

When is Revive Therapeutics' next earnings date?

Who are Revive Therapeutics' key executives?

Who are some of Revive Therapeutics' key competitors?

What other stocks do shareholders of Revive Therapeutics own?

What is Revive Therapeutics' stock symbol?

How do I buy shares of Revive Therapeutics?

What is Revive Therapeutics' stock price today?

How much money does Revive Therapeutics make?

What is Revive Therapeutics' official website?

Where are Revive Therapeutics' headquarters?

How can I contact Revive Therapeutics?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™